S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
pixel
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
pixel
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
pixel
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
pixel
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
NASDAQ:GTH

Genetron - GTH Stock Forecast, Price & News

$0.95
0.00 (-0.07%)
(As of 08/5/2022 08:48 PM ET)
Add
Compare
Today's Range
$0.90
$0.96
50-Day Range
$0.91
$1.70
52-Week Range
$0.90
$16.94
Volume
315,900 shs
Average Volume
285,530 shs
Market Capitalization
$86.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

Genetron MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
953.5% Upside
$10.00 Price Target
Short Interest
Healthy
1.27% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.81 out of 5 stars

Medical Sector

896th out of 1,283 stocks

Medical Laboratories Industry

22nd out of 30 stocks

GTH stock logo

About Genetron (NASDAQ:GTH) Stock

Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. The company has a strategic partnership with JD Health to create solutions for full-cycle cancer management. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the People's Republic of China.

Genetron Stock Performance

Shares of GTH Stock remained flat at $0.95 during trading hours on Friday. 315,928 shares of the stock traded hands, compared to its average volume of 330,895. The stock has a market cap of $86.00 million, a price-to-earnings ratio of -1.00 and a beta of 0.13. Genetron has a 1-year low of $0.90 and a 1-year high of $16.94. The business's 50-day moving average price is $1.38 and its two-hundred day moving average price is $2.21.

Genetron (NASDAQ:GTH - Get Rating) last announced its quarterly earnings data on Thursday, June 2nd. The company reported ($0.30) earnings per share for the quarter. The company had revenue of $17.40 million for the quarter. Genetron had a negative return on equity of 43.57% and a negative net margin of 101.62%.

Wall Street Analysts Forecast Growth

Separately, BTIG Research cut their price objective on shares of Genetron from $17.00 to $10.00 and set a "buy" rating on the stock in a report on Thursday, April 21st.

Receive GTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter.

GTH Stock News Headlines

Genetron (NASDAQ:GTH) Trading Down 4%
Genetron's Maryland lab gets CAP accreditation
Genetron reiterates FY21 revenue view RMB 530M
See More Headlines
Receive GTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter.

GTH Company Calendar

Last Earnings
6/02/2022
Today
8/08/2022
Next Earnings (Estimated)
8/23/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GTH
Fax
N/A
Employees
1,154
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.00
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+953.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-77,870,000.00
Net Margins
-101.62%
Pretax Margin
-103.51%

Debt

Sales & Book Value

Annual Sales
$83.47 million
Book Value
$2.14 per share

Miscellaneous

Free Float
N/A
Market Cap
$86.00 million
Optionable
Not Optionable
Beta
0.13

Key Executives

  • Mr. Sizhen Wang (Age 45)
    Co-Founder, CEO & Chairman
  • Dr. Wei-Wu He Ph.D. (Age 57)
    Co-Founder & Chairman Emeritus
  • Dr. Hai Yan (Age 54)
    Co-Founder, Chief Scientific Officer & Director
  • Mr. Ce Xu (Age 40)
    Chief Financial Officer
  • Dr. Yuchen Jiao M.D. (Age 44)
    Ph.D., Chief Technology Officer
  • Mr. Yong Liang (Age 48)
    Chief HR Officer
  • Dr. Yun-Fu Hu Ph.D. (Age 59)
    Chief Medical Officer
  • Ms. Victoria Lei
    Sr. VP













GTH Stock - Frequently Asked Questions

Should I buy or sell Genetron stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Genetron in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Genetron stock.
View analyst ratings for Genetron
or view top-rated stocks.

What is Genetron's stock price forecast for 2022?

1 brokers have issued 12-month target prices for Genetron's stock. Their GTH stock forecasts range from $10.00 to $10.00. On average, they expect Genetron's share price to reach $10.00 in the next year. This suggests a possible upside of 953.5% from the stock's current price.
View analysts' price targets for Genetron
or view top-rated stocks among Wall Street analysts.

How has Genetron's stock price performed in 2022?

Genetron's stock was trading at $6.10 at the start of the year. Since then, GTH shares have decreased by 84.4% and is now trading at $0.9492.
View the best growth stocks for 2022 here
.

Are investors shorting Genetron?

Genetron saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 1,060,000 shares, a decrease of 29.8% from the June 30th total of 1,510,000 shares. Based on an average trading volume of 244,100 shares, the short-interest ratio is currently 4.3 days. Currently, 1.3% of the shares of the company are short sold.
View Genetron's Short Interest
.

When is Genetron's next earnings date?

Genetron is scheduled to release its next quarterly earnings announcement on Tuesday, August 23rd 2022.
View our earnings forecast for Genetron
.

How were Genetron's earnings last quarter?

Genetron Holdings Limited (NASDAQ:GTH) released its quarterly earnings results on Thursday, June, 2nd. The company reported ($0.30) EPS for the quarter. The business had revenue of $17.40 million for the quarter. Genetron had a negative net margin of 101.62% and a negative trailing twelve-month return on equity of 43.57%.

What guidance has Genetron issued on next quarter's earnings?

Genetron issued an update on its FY 2022 earnings guidance on Thursday, June, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $92.28 million-$100.64 million, compared to the consensus revenue estimate of $92.50 million.

When did Genetron IPO?

(GTH) raised $162 million in an initial public offering (IPO) on Friday, June 19th 2020. The company issued 13,000,000 shares at a price of $11.50-$13.50 per share. Credit Suisse and CICC acted as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers.

What is Genetron's stock symbol?

Genetron trades on the NASDAQ under the ticker symbol "GTH."

Who are Genetron's major shareholders?

Genetron's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Legacy Wealth Asset Management LLC (0.02%).

How do I buy shares of Genetron?

Shares of GTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Genetron's stock price today?

One share of GTH stock can currently be purchased for approximately $0.95.

How much money does Genetron make?

Genetron (NASDAQ:GTH) has a market capitalization of $86.00 million and generates $83.47 million in revenue each year. The company earns $-77,870,000.00 in net income (profit) each year or ($0.95) on an earnings per share basis.

How many employees does Genetron have?

Genetron employs 1,154 workers across the globe.

How can I contact Genetron?

Genetron's mailing address is 1-2/F BUILDING 11 ZONE 1 CHANGPING DISTRICT, BEIJING F4, 102206. The official website for Genetron is www.genetronhealth.com. The company can be reached via phone at 86-10-5090-7500 or via email at ir@genetronhealth.com.

This page (NASDAQ:GTH) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.